SAN DIEGO --(BUSINESS WIRE)--Aug. 22, 2022-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: 2022 Wells Fargo Healthcare Conference on
SAN DIEGO --(BUSINESS WIRE)--Aug. 18, 2022-- Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that t:slim X2 insulin pump users have delivered more than 1 million insulin boluses using the t:connect app feature on their personal
SAN DIEGO --(BUSINESS WIRE)--Aug. 3, 2022-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2022 and updated its financial guidance for the year ending December 31, 2022 .
SAN DIEGO --(BUSINESS WIRE)--Jul. 21, 2022-- Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced its acquisition of infusion set developer, Capillary Biomedical. “Infusion sets provide people flexible options in insulin pump
SAN DIEGO --(BUSINESS WIRE)--Jul. 12, 2022-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2022 results after the financial markets close on Wednesday, August 3, 2022 .
SAN DIEGO --(BUSINESS WIRE)--Jun. 16, 2022-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today announced the appointments of Myoung Cha and Joao Malagueira as independent members of its board of directors effective June 15, 2022 .
NEW ORLEANS --(BUSINESS WIRE)--Jun. 6, 2022-- Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced positive real-world data demonstrating immediate and sustained benefits in a diverse cohort of people using the t:slim X2™ insulin pump with
SAN DIEGO --(BUSINESS WIRE)--May 18, 2022-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today announced that management will present a company update at the Piper Sandler Virtual Diabetes Symposium on Wednesday, May 25, 2022 at 11:00am
SAN DIEGO --(BUSINESS WIRE)--May 4, 2022-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2022 and updated its financial guidance for the year ending December 31, 2022
BARCELONA, Spain --(BUSINESS WIRE)--Apr. 27, 2022-- Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced real-world data confirming that use of the t:slim X2™ insulin pump with Control-IQ® advanced hybrid closed-loop technology resulted in
SAN DIEGO --(BUSINESS WIRE)--Apr. 11, 2022-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2022 results after the financial markets close on Wednesday, May 4, 2022 .
SAN DIEGO --(BUSINESS WIRE)--Mar. 7, 2022-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the Oppenheimer 32 nd Annual Healthcare Conference on Tuesday, March 15, 2022 at
SAN DIEGO --(BUSINESS WIRE)--Feb. 22, 2022-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2021 and financial guidance for the year ending December 31, 2022 .
First Smartphone App FDA cleared for Insulin Delivery on Both iOS and Android Operating Systems SAN DIEGO --(BUSINESS WIRE)--Feb. 16, 2022-- Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced U.S.
SAN DIEGO --(BUSINESS WIRE)--Feb. 11, 2022-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following virtual investor conferences: Citi’s 2022 Virtual Healthcare Conference
SAN DIEGO --(BUSINESS WIRE)--Jan. 19, 2022-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2021 results after the financial markets close on Tuesday, February 22, 2022 .
SAN DIEGO --(BUSINESS WIRE)--Dec. 2, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointments of Rick Carpenter as Chief Technical Officer, Libba Sapitsky as Senior Vice President, Customer Care, and Rizwan Pervez
SAN DIEGO --(BUSINESS WIRE)--Nov. 18, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, is scheduled to participate in the 33 rd Annual Piper Sandler Virtual Healthcare Conference on December 2, 2021 .
Virtual R&D Day Scheduled for December 6, 2021 SAN DIEGO --(BUSINESS WIRE)--Nov. 3, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2021 and updated its sales
SAN DIEGO --(BUSINESS WIRE)--Oct. 28, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following virtual investor conferences: Credit Suisse 30 th Annual Virtual
